Iqvia Holdings INC Form 4 insider transactions

IQVIA Holdings Inc. Director Colleen A. Goggins reported the acquisition of 198 deferred shares, increasing her beneficial ownership in the company.

IQVIA Holdings Inc. Director Jim Fasano acquired 211 deferred shares, convertible into common stock, as part of a pre-arranged plan.

IQVIA Holdings Inc. Director John G. Danhakl acquired 172 deferred shares, increasing his beneficial ownership to 2,944 deferred shares.

IQVIA Holdings Inc. EVP Bernd Haas is scheduled to acquire 8,265 shares of common stock through performance-based restricted stock units, increasing his direct beneficial ownership.

IQVIA Holdings Inc. President of Commercial Solutions, Alistair Grenfell, reported the vesting of performance-based restricted stock units and a subsequent tax-related disposition of shares.

IQVIA Holdings Inc. Senior Vice President Michael J. Fedock reported the acquisition of 6,735 shares of common stock from performance-based restricted stock units and subsequent tax-related dispositions.

IQVIA Holdings Inc. President, MedTech and Consumer Health, Bhavik Patel, reported the acquisition of shares from performance-based restricted stock units and subsequent tax-related dispositions.

IQVIA Holdings Inc. Executive Vice President Eric Sherbet acquired 6,806 shares of common stock through performance-based restricted stock units, subsequently disposing of 1,915 shares for tax purposes.

IQVIA Holdings Inc. President, Research & Development Solutions, W. Richard Staub, reported an acquisition of 2,722 shares and a disposition of 806 shares of common stock.

IQVIA Holdings Inc. SVP, Corporate Controller Keriann Cherofsky reported the vesting of performance-based restricted stock units and subsequent tax-related share disposition.

IQVIA Holdings Inc.'s EVP & CFO, Ronald E. Bruehlman, increased his direct beneficial ownership of common stock following the vesting of performance-based restricted stock units.

IQVIA Holdings Inc. EVP James G. Berkshire reported the acquisition of 2,722 shares of common stock due to performance criteria and the disposition of 1,280 shares for tax purposes.

IQVIA Holdings Inc. CEO Ari Bousbib reported the acquisition of 57,177 shares of common stock from performance-based restricted stock units and the disposition of 28,399 shares for tax withholding.

IQVIA Holdings Inc. SVP Michael J. Fedock filed a Form 4 disclosing a future disposition of 381 common shares on January 28, 2026, to cover tax withholding obligations.

IQVIA Holdings Inc.'s Chairman, CEO, and President, Ari Bousbib, exercised stock appreciation rights and subsequently sold a portion of the acquired common stock.

IQVIA Holdings Inc. Director Morris Leslie Wims acquired 146 deferred shares, increasing beneficial ownership to 4,735 deferred shares.

IQVIA Holdings Inc. director Colleen A. Goggins acquired 181 deferred shares, increasing her beneficial ownership to 4,702 deferred shares.

IQVIA Holdings Inc. Director Jim Fasano acquired 193 deferred shares, increasing his beneficial ownership to 4,063 shares.

IQVIA Holdings Inc. Director John G. Danhakl acquired 158 deferred shares, convertible into common stock, valued at $210.12 per share.

IQVIA Holdings Inc. Executive Vice President and General Counsel Eric Sherbet exercised stock appreciation rights and subsequently sold 10,000 shares of common stock.

IQVIA Holdings Inc. CEO Ari Bousbib exercised stock appreciation rights and subsequently sold 77,592 shares of common stock on October 29, 2025.

IQVIA Holdings Inc. officer Bhavik Patel reported the disposition of 84 shares of common stock to cover tax liabilities at a price of $197.76 per share.

IQVIA Holdings Inc.'s SVP, Corporate Controller, Keriann Cherofsky, reported the disposition of 35 shares of common stock for tax purposes at a price of $197.76 per share.

IQVIA Holdings Inc. Director Colleen A. Goggins acquired 174 deferred shares, increasing her beneficial ownership to 4,521 deferred shares.

IQVIA Holdings Inc. Director Morris Leslie Wims acquired 137 deferred shares, increasing his direct beneficial ownership to 4,589 deferred shares.

IQVIA Holdings Inc. Director Jim Fasano acquired 187 deferred shares, increasing his beneficial ownership to 3,870 deferred shares.

IQVIA Holdings Inc. Director John G. Danhakl reported the acquisition of 149 deferred shares, convertible into common stock, effective July 24, 2025.

IQVIA Holdings Inc.'s Senior Vice President and Corporate Controller, Keriann Cherofsky, sold 549 shares of common stock for $191.53 per share under a Rule 10b5-1 trading plan.

IQVIA Holdings Inc. Executive Vice President and General Counsel Eric Sherbet reported the exercise of stock appreciation rights and subsequent sale of common stock.

Director Leslie Wims Morris acquired 179 deferred shares of IQVIA Holdings Inc. convertible to common stock upon certain events.